Literature DB >> 10686169

Tourette syndrome, associated conditions and the complexities of treatment.

M M Robertson1.   

Abstract

Tourette syndrome (TS) is characterized by multiple motor tics plus one or more vocal (phonic) tics, which characteristically wax and wane. It can no longer be considered the rare and bizarre syndrome that it was once thought to be. The concepts surrounding TS, and our understanding of it, are also becoming increasingly complex and, in some individuals, TS is now recognized to be associated with a wide variety of associated behaviours and psychopathologies. It is suggested that TS is heterogeneous from a variety of standpoints including clinical presentation and psychopathology, and thus neuropharmacological responses and possibly even aetiological and genetic mechanisms. In this paper, mention is made of recent findings in epidemiology and genetics, highlighting the complexities of the disorder; these have been chosen because findings in both areas have clinical and management implications. The literature on the clinical manifestations, associated behaviours, psychopathology (and/or comorbid conditions) and management, in particular, is reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686169     DOI: 10.1093/brain/123.3.425

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  118 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors:  A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

3.  Indications of linkage and association of Gilles de la Tourette syndrome in two independent family samples: 17q25 is a putative susceptibility region.

Authors:  P Paschou; Y Feng; A J Pakstis; W C Speed; M M DeMille; J R Kidd; B Jaghori; R Kurlan; D L Pauls; P Sandor; C L Barr; K K Kidd
Journal:  Am J Hum Genet       Date:  2004-08-09       Impact factor: 11.025

Review 4.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

5.  Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome.

Authors:  Renata Rizzo; Mariangela Gulisano; Paola Valeria Calì
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-13       Impact factor: 4.785

6.  Can HIV infection cause a worsening of tics in Tourette patients?

Authors:  F Antonelli; V Borghi; G Galassi; P Nichelli; F Valzania
Journal:  Neurol Sci       Date:  2010-09-25       Impact factor: 3.307

Review 7.  Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.

Authors:  Paul R Sanberg; Cecilia Vindrola-Padros; R Douglas Shytle
Journal:  Physiol Behav       Date:  2012-07-06

Review 8.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

Review 9.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

10.  Schizotypal personality traits in Gilles de la Tourette syndrome.

Authors:  A E Cavanna; M M Robertson; H D Critchley
Journal:  Acta Neurol Scand       Date:  2007-12       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.